This protocol is judged by an institutional evaluation board, an impartial group that assessments any scientific trials involving people. If a review involves a Program I drug, once the board approves the protocol as ethical, the scientists really have to apply for an investigational new drug (IND) selection in the FDA.Luckily, other providers wit